Centenarians carry a younger protein signature in their blood
People who live to 100 aren’t just older versions of 80-year-olds. Their blood tells a different biological story.
Researchers analyzed blood plasma from centenarians and compared it to two other groups: younger healthy adults and hospitalized elderly people aged 80 to 90. They found 583 proteins that differ in centenarians compared to both groups. The study, published in Aging Cell, used data from the SWISS100 cohort and applied proteomics, a technique that measures thousands of proteins simultaneously.
Among the 583 differing proteins, 37 stood out. These resembled the protein patterns seen in younger adults more than those of other elderly people. The 37 proteins are linked to four processes: programmed cell death, metabolic pathways, extracellular matrix stability (the structural tissue surrounding cells), and regulation of inflammation. These are precisely the processes that come under pressure as the body ages.
Not immortal, just different
Centenarians are not immune to aging. They are frail, experience significant health challenges, and have high mortality rates. That is what makes them such a useful research group. They reach extreme age despite the same biological wear and tear that kills others earlier. The key question is: what offers them relative protection?
Among the 37 proteins with a younger profile, the researchers also noted links to neurotrophic signaling, a process through which brain cells receive growth signals to stay alive. This connection is preliminary and requires further investigation, but it hints at a broader biological pattern associated with healthier aging.
From pattern to target
The researchers cross-referenced their findings with a second, independent proteomics study on centenarians. In both studies, 135 proteins deviated in the same direction. That consistency makes these findings more robust than what individual studies had previously shown.
The goal of this kind of research is not simply to reach 100, but to understand which biological processes most drive functional decline. From a longevity perspective, the 37 proteins with a younger profile are potentially interesting targets for future treatments, though that remains speculative at this stage.
Search terms: centenarian proteomics, extracellular matrix aging, neurotrophic signaling